4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001924908-26-000005
Options or other derivatives
- Chief Legal Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Adler Reid G. Chief Legal Officer | 2026-04-07 | Grant or award · Incentive Stock Option (right to buy) | +18,753 | 18,753 | D | ||
| Adler Reid G. Chief Legal Officer | 2026-04-07 | Grant or award · Non-Qualified Stock Option (right to buy) | +56,247 | 56,247 | D | ||
Loading xslF345X06/edgardoc.xml…